← FDA Drug Approvals (Drugs@FDA)

VANFLYTA

NDA · New Drug Application · Sponsor: DAIICHI SANKYO INC · Approved 2023-07-20

Drug application

FDA Application #

NDA216993

Application type

New Drug Application

Brand name

VANFLYTA

Generic name

QUIZARTINIB

Active ingredients

QUIZARTINIB DIHYDROCHLORIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

DAIICHI SANKYO INC

Manufacturer

Daiichi Sankyo Inc.

First approval

2023-07-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown